Evidence map›Paper›PMID 31876494›Full record

ArticleThe Lancet. Infectious diseases2020

8-year M type surveillance of Streptococcus pyogenes in China.

Yuanhai You, Xiaomin Peng, Peng Yang, Quanyi Wang, Jianzhong Zhang

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Invasive Infection WithFrontiers in medicine · 2022
    Article
  8. Molecular Characteristics ofFrontiers in microbiology · 2021
    Article
  9. Epidemiological analysis of Group A Streptococcus infections in a hospital in Beijing, China.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Yuanhai YouState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Xiaomin PengBeijing Center for Disease Control and Prevention, Beijing 100013, China.
Peng YangBeijing Center for Disease Control and Prevention, Beijing 100013, China.
Quanyi WangBeijing Center for Disease Control and Prevention, Beijing 100013, China. Electronic address: bjcdcxm@126.com.
Jianzhong ZhangState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. Electronic address: zhangjianzhong@icdc.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Scarlet FeverStreptococcal InfectionsChinaEnglandEpidemiologic StudiesHumansStreptococcus pyogenes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.